• According to Transparency Market Research’s latest report on the global diagnostic specialty antibody market for the historical period 2017–2018 and forecast period 2019–2027, advancements in antibody development technology have revolutionized the diagnostic science through which antibodies can be produced against any pathogenic antigen and transformed the diagnostic industry.
  • According to the report, the global diagnostic specialty antibody market was valued at US$ 22.6 Bn in 2018 and is anticipated to expand at a CAGR of 5.3% from 2019 to 2027

To know the scope of our report Get a Sample on Diagnostic Specialty Antibodies Market?

Increase in Reported Cases of Diagnostic Specialty Antibody: A Key Driver

  • Increase in clinical research, evolution of infectious diseases, and unhealthy lifestyle of the population has led to innovation of new biological drugs as well as diagnostic kits. Several biotechnology and biopharmaceutical companies offer different diagnostic assays to meet the unmet medical needs of the health care system, which augment the diagnostic specialty antibody market.
  • In 2014, Epitope Diagnostics, Inc. launched a new set of monoclonal antibody MMAE-ADC and MMAF-ADC ELISA kits, which are specific to detecting monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF), the two anti-cancer compounds. Launch of such innovative antibody based diagnostic kits is likely to enable the measurement of the disease condition more accurately. This is likely to increase interest of diagnostic laboratories and hospitals to use these products, which are likely ti augment the growth of diagnostic specialty antibody market
  • Governments of several countries are investing in diagnostic health care. According to the World Bank, global healthcare expenditure was 6% of GDP. In 2016, world health care expenditure was US$ 6.5 Trn. In 2015, health care spending in the U.S. increased by 5.8% to reach US$ 3.2 Trn. The overall share of the U.S. economy devoted to health care spending was 17.8% in 2015, up from 17.4% in 2014. In 2015, total government health care expenditure in Europe was 7.2% of GDP.
  • With respect to government investment in developing antibody-based diagnostic kits, in February 2018, the Bio & Medical Technology Development Program of the National Research Foundation of Korea developed a rapid diagnostic test kit to detect IgG and IgM antibody against Zika virus using monoclonal antibodies and the whole research was funded by the Government of South Korea, likely to drive the diagnostic specialty antibody market.

Get a glimpse of the in-depth analysis through our Report Brochure

Failure of Antibodies in Rapid Diagnostic Test for Routine Diagnosis to Hamper Global Diagnostic Specialty Antibody Market

  • The Ministry of Health and Family Welfare, Government of India, indicated that the use of antibody detecting rapid diagnostic test (ADRDTs) is not the solution to diagnosis of diseases such as malaria, because serelogical testing is not practical for routine diagnosis of an acute parasite infectious disease in terms of the time required for development of antibody. Moreover, in endemic areas of India, the antibody detecting rapid diagnostic test gave false positive test results, as patients suffer due to other reasons. Hence, from March 2018, the Ministry of Health and Family Welfare, prohibited the use of antibody detecting rapid diagnostic tests for routine diagnosis of malaria. Such incidences are projected to hamper the growth of the diagnostic specialty antibody market.

North America to Account for Major Share of Global Diagnostic specialty antibody Market

  • North America leads the global diagnostic specialty antibody market commanding more than 40% share in the global diagnostic specialty antibody market. Recent advances in diagnostic specialty antibody diagnostics, reimbursement for disease screening, and improved access to diagnostics are the major drivers of the diagnostic specialty antibody market in North America.  U.S. is expected to hold major share in the North America diagnostic specialty antibody market during the forecast period, owing to developed health care infrastructure in the region and large patient population along with increasing technological development.
  • Increase in government intervention in the emerging markets has led to rise in awareness about diseases and improvement in the health care infrastructure. Additionally, socioeconomic development has been observed in emerging economies such as Asia, Africa, and Latin America. These factors contribute to the overall increase in spending capacity of the population which likely expect to increase market share of Asia, Africa, and Latin America diagnostic specialty antibody market.
  • Moreover, prevalence of life threatening diseases and infectious diseases such as COVID-19 is high in these regions. According to the WHO estimates, 4.2 million cases were detected till May 13 2020, with nearly 2.9 lakh COVID-19 related deaths. The number of COVID cases is expected to increase across the globe, with 50% of cases in Africa, Asia, and Latin America. Hence, increase in investment in these emerging markets is a major opportunity for key players, and these are anticipated to be major markets for diagnostic specialty antibody infection.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Diagnostic Specialty Antibody Market: Competitive Landscape

  • This report profiles major players in the global diagnostic specialty antibody market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the global diagnostic specialty antibody market include Abcam plc, Sanofi, Abbott laboratories, Hoffmann-La Roche Ltd., Danaher Corporation, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc.
  • Leading players operating in the global diagnostic specialty antibody market are
    • F. Hoffmann-La Roche Ltd
    • Sanofi
    • Abbott Laboratories.
  • These players offer products with proprietary technologies. Others include
    • Abcam plc
    • Bio-Rad Laboratories, Inc.
    • Boehringer Ingelheim International GmbH
    • Agilent Technologies, Inc.
    • Aytu BioScience, Inc.
    • Aytu Bioscience, Inc.
  • invests in research and developmental activities to develop new and innovative products. It recently acquired and anticipates to commercialize FDA-approved ProstaScint (capromab pendetide), a radiolabeled monoclonal antibody. In January 2016, the company acquired a high-performance analytical flow cytometer platform from Propel Labs. This enables advanced and novice users to perform basic and multi-parameter cytometry for a wide range of applications and chemistries.

Global Diagnostic Specialty Antibody Market: Key Developments

High unmet needs in the global diagnostic specialty antibody market present lucrative opportunities for existing players and new entrants. For instance, Abcam plc plans to strengthen its position in Asia, specifically in China, to increase market share in unpenetrated segments and offer custom products and licensing. Additionally, in November 2016, Roche launched the global cancer immunotherapy Centers of Research Excellence (imCORE) network which brings together world’s leading scientific and clinical experts in cancer immunotherapy to collaborate in investigating promising new treatment approaches. The company announced investment up to CHF 100 Mn (US$ 98 Mn) to support basic and clinical research collaborations related to cancer immunotherapy.

The report on the global diagnostic specialty antibody market discusses individual strategies followed by company profiles of manufacturers of diagnostic specialty antibody treatment products. The competitive landscape section has been included in the diagnostic specialty antibody market report to provide readers with a dashboard view and a company diagnostic specialty antibody market share analysis of key players operating in the global diagnostic specialty antibody market.

TMR’s report on the global diagnostic specialty antibody market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2019–2027. The report provides the revenue of the global diagnostic specialty antibody market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global diagnostic specialty antibody market during the forecast period.

 

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global diagnostic specialty antibody market.

 

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global diagnostic specialty antibody market.

 

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global diagnostic specialty antibody market. These indices serve as valuable tools for existing players in the diagnostic specialty antibody market as well as for entities interested in entering the global market.

 

The report delves into the competitive landscape of the global diagnostic specialty antibody market. Key players operating in the global diagnostic specialty antibody market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Diagnostic Specialty Antibody market that have been profiled in this report.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Global Diagnostic Specialty Antibody Market – Segmentation

 

 

 

Antibody Type

End-user

Application

Region

Monoclonal Antibodies

Hospitals

Hepatitis Diagnosis

North America

Polyclonal Antibodies

Diagnostic Laboratories

Tuberculosis Diagnostics

Europe

Recombinant Polyclonal Antibodies

Others

Dengue Diagnostics

Asia Pacific

 

 

Oncology Diagnostics

Latin America

 

 

HIV Diagnostics

Middle East & Africa

 

 

Infectious Disease Diagnostics

 

 

 

Others Diagnostics

 

 

 

Key Questions Answered in Global Diagnostic Specialty Antibody Market Report

 

  • What is the scope of growth of product companies in the global diagnostic specialty antibody market?
  • What will be the Y-o-Y growth of the global diagnostic specialty antibody market between 2019 and 2027?
  • What is the influence of changing trends in antibodies on the global diagnostic specialty antibody market?
  • Will North America continue to be the most profitable market for providers of diagnostic specialty antibody treatment products?
  • Which factors will hamper the growth of the global diagnostic specialty antibody market during the forecast period?
  • Which are the leading companies in the global diagnostic specialty antibody market?

 

 

Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global diagnostic specialty antibody market and arrive at conclusions on the growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred by analysts during the production of the global diagnostic specialty antibody market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global diagnostic specialty antibody market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from leaders in the diagnostic specialty antibody market. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global diagnostic specialty antibody market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and two bottom-up approaches to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global diagnostic specialty antibody market more reliably and accurately.

Regional Segmentation of Global Diagnostic Specialty Antibody Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global diagnostic specialty antibodies market has been segmented as follows:

Antibody Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Polyclonal Antibodies

Application

  • Hepatitis Diagnosis
  • Tuberculosis Diagnostics
  • Dengue Diagnostics
  • Oncology Diagnostics
  • HIV Diagnostics
  • Infectious Disease Diagnostics
  • Others

End-user

  • Hospitals
  • Diagnostic Laboratories
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Diagnostic Specialty Antibody Market

4. Market Overview

    4.1. Introduction

        4.1.1. Antibody Type Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Diagnostic Specialty Antibody Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Disease Prevalence & Incidence Rate globally with key countries / Region

    5.2. Pipeline Analysis

    5.3. Key Industry Developments

6. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Antibody Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Antibody Type, 2017–2027

        6.3.1. Monoclonal Antibodies

        6.3.2. Polyclonal Antibodies

        6.3.3. Recombinant Polyclonal Antibodies

    6.4. Market Attractiveness, by Antibody Type 

7. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by End-user 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2027

        7.3.1. Hospitals

        7.3.2. Diagnostic Laboratories

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Application 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2017–2027

        8.3.1. Hepatitis Diagnosis

        8.3.2. Tuberculosis Diagnostics

        8.3.3. Dengue Diagnostics

        8.3.4. Oncology Diagnostics

        8.3.5. HIV Diagnostics

        8.3.6. Infectious Disease Diagnostics

        8.3.7. Others Diagnostics

    8.4. Market Attractiveness Analysis, by Application

9. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness Analysis, by Region

10. North America Diagnostic Specialty Antibody Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast By Antibody Type, 2017–2027

        10.2.1. Monoclonal Antibodies

        10.2.2. Polyclonal Antibodies

        10.2.3. Recombinant Polyclonal Antibodies

    10.3. Market Value Forecast, by End-user, 2017–2027

        10.3.1. Hospitals

        10.3.2. Diagnostic Laboratories

        10.3.3. Others

    10.4. Market Value Forecast, by Application, 2017–2027

        10.4.1. Hepatitis Diagnosis

        10.4.2. Tuberculosis Diagnostics

        10.4.3. Dengue Diagnostics

        10.4.4. Oncology Diagnostics

        10.4.5. HIV Diagnostics

        10.4.6. Infectious Disease Diagnostics

        10.4.7. Others Diagnostics

    10.5. Market Value Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Antibody Type 

        10.6.2. By End-user 

        10.6.3. By Application

        10.6.4. By Country

11. Europe Diagnostic Specialty Antibody Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Antibody Type, 2017–2027

        11.2.1. Monoclonal Antibodies

        11.2.2. Polyclonal Antibodies

        11.2.3. Recombinant Polyclonal Antibodies

    11.3. Market Value Forecast, by End-user, 2017–2027

        11.3.1. Hospitals

        11.3.2. Diagnostic Laboratories

        11.3.3. Others

    11.4. Market Value Forecast, by Application, 2017–2027

        11.4.1. Hepatitis Diagnosis

        11.4.2. Tuberculosis Diagnostics

        11.4.3. Dengue Diagnostics

        11.4.4. Oncology Diagnostics

        11.4.5. HIV Diagnostics

        11.4.6. Infectious Disease Diagnostics

        11.4.7. Others Diagnostics

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis 

        11.6.1. By Antibody Type 

        11.6.2. By End-user 

        11.6.3. By Application

        11.6.4. By Country/Sub-region

12. Asia Pacific Diagnostic Specialty Antibody Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Antibody Type, 2017–2027

        12.2.1. Monoclonal Antibodies

        12.2.2. Polyclonal Antibodies

        12.2.3. Recombinant Polyclonal Antibodies

    12.3. Market Value Forecast, by End-user, 2017–2027

        12.3.1. Hospitals

        12.3.2. Diagnostic Laboratories

        12.3.3. Others

    12.4. Market Value Forecast, by Application, 2017–2027

        12.4.1. Hepatitis Diagnosis

        12.4.2. Tuberculosis Diagnostics

        12.4.3. Dengue Diagnostics

        12.4.4. Oncology Diagnostics

        12.4.5. HIV Diagnostics

        12.4.6. Infectious Disease Diagnostics

        12.4.7. Others Diagnostics

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Antibody Type 

        12.6.2. By End-user 

        12.6.3. By Application

        12.6.4. By Country/Sub-region

13. Latin America Diagnostic Specialty Antibody Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Antibody Type, 2017–2027

        13.2.1. Monoclonal Antibodies

        13.2.2. Polyclonal Antibodies

        13.2.3. Recombinant Polyclonal Antibodies

    13.3. Market Value Forecast, by End-user, 2017–2027

        13.3.1. Hospitals

        13.3.2. Diagnostic Laboratories

        13.3.3. Others

    13.4. Market Value Forecast, by Application, 2017–2027

        13.4.1. Hepatitis Diagnosis

        13.4.2. Tuberculosis Diagnostics

        13.4.3. Dengue Diagnostics

        13.4.4. Oncology Diagnostics

        13.4.5. HIV Diagnostics

        13.4.6. Infectious Disease Diagnostics

        13.4.7. Others Diagnostics

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Antibody Type 

        13.6.2. By End-user 

        13.6.3. By Application

        13.6.4. By Country/Sub-region

14. Middle East & Africa Diagnostic Specialty Antibody Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Antibody Type, 2017–2027

        14.2.1. Monoclonal Antibodies

        14.2.2. Polyclonal Antibodies

        14.2.3. Recombinant Polyclonal Antibodies

    14.3. Market Value Forecast, by End-user, 2017–2027

        14.3.1. Hospitals

        14.3.2. Diagnostic Laboratories

        14.3.3. Others

    14.4. Market Value Forecast, by Application, 2017–2027

        14.4.1. Hepatitis Diagnosis

        14.4.2. Tuberculosis Diagnostics

        14.4.3. Dengue Diagnostics

        14.4.4. Oncology Diagnostics

        14.4.5. HIV Diagnostics

        14.4.6. Infectious Disease Diagnostics

        14.4.7. Others Diagnostics

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis 

        14.6.1. By Antibody Type 

        14.6.2. By End-user 

        14.6.3. By Application

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (By Tier and Size of companies)

    15.2. Market Share/Position Analysis, by Company, 2018

    15.3. Company Profiles

        15.3.1. Abcam plc

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis

        15.3.2. F. Hoffmann-La Roche Ltd. 

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis

        15.3.3. Abbott Laboratories

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis

        15.3.4. Sanofi

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis

        15.3.5. Bio-Rad Laboratories, Inc.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis

        15.3.6. Boehringer Ingelheim International GmbH

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis

        15.3.7. Agilent Technologies, Inc. 

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis

        15.3.8. Aytu BioScience, Inc.  

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis of Diagnostic Specialty Antibody (1/2)

Table 02: Pipeline Analysis of Diagnostic Specialty Antibody (2/2)

Table 03: Global Diagnostic Specialty Antibody Market Size (US$ Mn) Forecast, by Antibody Type, 2017–2027

Table 04: Global Diagnostic Specialty Antibody Market Size (US$ Mn)  Forecast, by Application, 2017–2027

Table 05: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 06: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 07: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 08: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027

Table 09: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 10: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 11: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2027

Table 12: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027

Table 13: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 14: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/ Sub-Region, 2017–2027

Table 16: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027

Table 17: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 18: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 19: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027

Table 21: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 22: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 23: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 24: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027

Table 25 : Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 26: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Diagnostic Specialty Antibody Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Market Snapshot of Global Diagnostic Specialty Antibody Market 

Figure 03: Market Opportunity Map, Revenue Share, by Antibody Type

Figure 04: Market Opportunity Map, Revenue Share, by Application

Figure 05: Recent Key Industry Events of Diagnostic Specialty Antibody Market 

Figure 06: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, 2017–2027

Figure 07: Market Value Share, by End-user, 2017

Figure 08: Market Value Share, by Antibody Type, 2017

Figure 09: Market Value Share, by Region, 2017

Figure 10: Market Value Share, by Application, 2017

Figure 11: Patent Filling Details of Various Diagnostic Antibody

Figure 12: Patent Filling Details of Various Diagnostic Antibody

Figure 13: Patent Filling Details of Various Diagnostic Antibody

Figure 14 : Global Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027

Figure 15: Global Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027

Figure 16: Global Monoclonal Antibodies Market Revenue

Figure 17: Global Polyclonal Antibodies Market Revenue

Figure 18: Global Recombinant Polyclonal Antibodies Market Revenue

Figure 19: Global Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027

Figure 20: Global Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027

Figure 21: Global Hepatitis Diagnostic Specialty Antibody Market Revenue

Figure 22: Global Tuberculosis Diagnostic Specialty Antibody Market Revenue

Figure 23: Global Dengue Diagnostic Specialty Antibody Market Revenue

Figure 24: Global Oncology Diagnostics Diagnostic Specialty Antibody Market Revenue

Figure 25: Global HIV Diagnostics Diagnostic Specialty Antibody Market Revenue

Figure 26: Global Infectious Disease Diagnostics Diagnostic Specialty Antibody Market Revenue

Figure 27: Global Other Diagnostics Diagnostic Specialty Antibody Market Revenue

Figure 28: Global Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027

Figure 29: Global Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027

Figure 30: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027

Figure 31: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2017–2027

Figure 32: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027

Figure 32: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027

Figure 33: Global Diagnostic Specialty Antibody Market Value Share, by Region, 2018 and 2027

Figure 34: Global Diagnostic Specialty Antibody Market Attractiveness, by Region, 2019–2027

Figure 35: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027 

Figure 36: North America Diagnostic Specialty Antibody Market Value Share, by Country, 2018 and 2027

Figure 37: North America Diagnostic Specialty Antibody Market Attractiveness, by Country, 2019–2027

Figure 38: North America Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027

Figure 39: North America Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027

Figure 40: North America Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027

Figure 41: North America Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027

Figure 42: North America Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027

Figure 43: North America Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027

Figure 44: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 45: Europe Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027

Figure 46: Europe Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 47: Europe Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027

Figure 48: Europe Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027

Figure 49: Europe Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027

Figure 50: Europe Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027

Figure 51: Europe Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027

Figure 52: Europe Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027

Figure 53: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 54: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027

Figure 55: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 56: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027

Figure 57: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027

Figure 58: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027

Figure 59: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027

Figure 60: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027

Figure 61: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027

Figure 62: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 63: Latin America Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027

Figure 64: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 65: Latin America Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027

Figure 66: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027

Figure 67: Latin America Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027

Figure 68: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027

Figure 69: Latin America Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027

Figure 70: Latin America Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027

Figure 71: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 72: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027

Figure 73: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 74: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027

Figure 75: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027

Figure 76: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027

Figure 77: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027

Figure 78: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027

Figure 79: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Diagnostic Specialty Antibodies Market